Xiao Zheng, Ray Madhumita, Jiang Chuancang, Clark Alan B, Rogozin Igor B, Diaz Marilyn
Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, D3-01, 111 T.W. Alexander Drive, Research Triangle Park, NC 27709, USA.
Mol Immunol. 2007 Apr;44(10):2659-66. doi: 10.1016/j.molimm.2006.12.006. Epub 2007 Jan 22.
The basis for mutations at A:T base pairs in immunoglobulin hypermutation and defining how AID interacts with the DNA of the immunoglobulin locus are major aspects of the immunoglobulin mutator mechanism where questions remain unanswered. Here, we examined the pattern of mutations generated in mice deficient in various DNA repair proteins implicated in A:T mutation and found a previously unappreciated bias at G:C base pairs in spectra from mice simultaneously deficient in DNA mismatch repair and uracil DNA glycosylase. This suggests a strand-biased DNA transaction for AID delivery which is then masked by the mechanism that introduces A:T mutations. Additionally, we asked if any of the known components of the A:T mutation machinery underscore the basis for the paucity of A:T mutations in the Burkitt lymphoma cell lines, Ramos and BL2. Ramos and BL2 cells were proficient in MSH2/MSH6-mediated mismatch repair, and express high levels of wild-type, full-length DNA polymerase eta. In addition, Ramos cells have high levels of uracil DNA glycosylase protein and are proficient in base excision repair. These results suggest that Burkitt lymphoma cell lines may be deficient in an unidentified factor that recruits the machinery necessary for A:T mutation or that AID-mediated cytosine deamination in these cells may be processed by conventional base excision repair truncating somatic hypermutation at the G:C phase. Either scenario suggests that cytosine deamination by AID is not enough to trigger A:T mutation, and that additional unidentified factors are required for full spectrum hypermutation in vivo.
免疫球蛋白超突变中A:T碱基对处突变的基础以及确定激活诱导胞嘧啶脱氨酶(AID)如何与免疫球蛋白基因座的DNA相互作用,是免疫球蛋白突变机制的主要方面,其中一些问题仍未得到解答。在这里,我们研究了在与A:T突变相关的各种DNA修复蛋白缺陷的小鼠中产生的突变模式,发现在同时缺乏DNA错配修复和尿嘧啶DNA糖基化酶的小鼠的突变谱中,G:C碱基对存在一种以前未被认识到的偏向性。这表明AID传递存在链偏向性的DNA交易,随后被引入A:T突变的机制所掩盖。此外,我们询问A:T突变机制的任何已知成分是否可以解释伯基特淋巴瘤细胞系Ramos和BL2中A:T突变稀少的原因。Ramos和BL2细胞在MSH2/MSH6介导的错配修复方面功能正常,并表达高水平的野生型全长DNA聚合酶η。此外,Ramos细胞具有高水平的尿嘧啶DNA糖基化酶蛋白,并且在碱基切除修复方面功能正常。这些结果表明,伯基特淋巴瘤细胞系可能缺乏一种未鉴定的因子,该因子招募A:T突变所需的机制,或者这些细胞中AID介导的胞嘧啶脱氨作用可能通过常规碱基切除修复进行处理,从而在G:C阶段截断体细胞超突变。这两种情况都表明,AID介导的胞嘧啶脱氨不足以触发A:T突变,并且体内全谱超突变还需要其他未鉴定的因子。